140350_CD
pp82-93_JJ
27_CD
2_CD
03_CD
8:43_CD
pm_NN
Page_NN
91_CD
ADDITIONAL_NN
INFORMATION_NOMZ
FOR_PIN
US_FPP1
INVESTORS_NN
REED_NN
ELSEVIER_NN
NV_NN
Summary_NN
financial_JJ
information_NOMZ
in_PIN
US_FPP1
dollars_NN
Basis_NN
of_PIN
preparation_NOMZ
The_DT
summary_NN
financial_JJ
information_NOMZ
is_VPRT [BEMA]
a_DT
simple_JJ
translation_NOMZ
of_PIN
Reed_NN
Elsevier_NN
NV_NN
statutory_JJ
financial_JJ
statements_NOMZ
into_PIN
US_FPP1
dollars_NN
at_PIN
the_DT
stated_VBN [PUBV]
rates_NN
of_PIN
exchange_NN
._.
The_DT
financial_JJ
information_NOMZ
provided_VBN [WZPAST]
below_PLACE
is_VPRT [PASS]
prepared_VBN
under_IN
Dutch_JJ
GAAP_NN
as_IN
used_VBN
in_PIN
the_DT
preparation_NOMZ
of_PIN
the_DT
Reed_NN
Elsevier_NN
NV_NN
statutory_JJ
financial_JJ
statements_NOMZ
._.
It_PIT
does_VPRT
not_XX0
represent_VB
a_DT
restatement_NOMZ
under_IN
US_FPP1
GAAP_NN
which_WDT [WHSUB]
would_PRMD
be_VB [BEMA]
different_PRED
in_PIN
some_QUAN
significant_JJ
respects_NN
._.
Profit_NN
and_PHC
loss_NN
account_NN
For_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2002 2002 2001_CD
US$_$
m_CD
US$_$
m_CD [PASS]
Adjusted_VBN
profit_NN
attributable_JJ
511_CD
450_CD
Data_NN
per_PIN
American_NN
Depositary_NN
Share_NN
2002_CD
2001_CD
US$_$
m_CD
US$_$
m_CD
Earnings_GER
per_PIN
American_JJ
Depositary_NN
Share_NN
based_VBN [WZPAST]
on_PIN
50_CD
%_NN
interest_NN
in_PIN
Reed_NN
Elsevier_NN
combined_JJ
businesses_NOMZ
Adjusted_VBN
$_$
1.30_CD
$_$
1.14_CD
Basic_JJ
$_$
0.34_CD
$_$
0.23_CD
Net_JJ
dividend_NN
per_PIN
American_JJ
Depositary_NN
Share_NN
$_$
0.57_CD
$_$
0.540_CD
Balance_NN
sheet_NN
As_IN
at_PIN
31_CD
December_NN
2002 2002 2001_CD
US$_$
m_CD
US$_$
m_CD
Shareholders_NN
funds_NN
2,128_CD
2,115_CD
Exchange_NN
rates_NN
for_PIN
translation_NOMZ
of_PIN
euros_NN
:_:
$_$
1_CD
2002_CD
2001_CD
Profit_NN
and_PHC
loss_NN
1.060_CD
1.118_CD
Balance_NN
sheet_NN
0.956_CD
1.131_CD
Adjusted_VBN
earnings_GER
per_PIN
American_JJ
Depositary_NN
Share_NN
is_VPRT [PASS]
based_VBN
on_PIN
Reed_NN
Elsevier_NN
NVs_NN
50_CD
%_NN
share_NN
of_PIN
the_DT
adjusted_JJ
profit_NN
attributable_JJ
of_PIN
the_DT
Reed_NN
Elsevier_NN
combined_JJ
businesses_NOMZ
,_,
which_WDT [SERE]
excludes_VPRT
amortisation_NOMZ
of_PIN
goodwill_NN
and_CC
intangible_JJ
assets_NN
and_CC
exceptional_JJ
items_NN
._.
Adjusted_VBN
figures_NN
are_VPRT [PASS]
described_VBN
in_PIN
note_NN
3_CD
to_PIN
the_DT
Reed_NN
Elsevier_NN
NV_NN
statutory_JJ
financial_JJ
statements_NOMZ
._.
Reed_NN
Elsevier_NN
NV_NN
shares_NN
are_VPRT [PASS]
quoted_VBN
on_PIN
the_DT
New_NN
York_NN
Stock_NN
Exchange_NN
and_PHC
trading_GER
is_VPRT [BEMA]
in_PIN
the_DT
form_NN
of_PIN
American_JJ
Depositary_NN
Shares_NN
ADSs_NN
,_,
evidenced_VBN [PASTP]
by_PIN
American_JJ
Depositary_NN
Receipts_NN
ADRs_NN
,_,
representing_VBG [PRESP]
two_CD
Reed_NN
Elsevier_NN
NV_NN
ordinary_JJ
shares_NN
of_PIN
0.06_CD
each_QUAN
._.
758204101_CD
:_:
trading_GER
symbol_NN
,_,
ENL_NN
:_:
Citibank_NN
is_VPRT [BEMA]
the_DT
ADS_NN
Depositary_NN
._.
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
STATEMENTS_NOMZ
2002 91 140350_CD
pp82-93_JJ
27_CD
2_CD
03_CD
8:43_CD
pm_NN
Page_NN
92_CD
ADDITIONAL_NN
INFORMATION_NOMZ
FOR_PIN
US_FPP1
INVESTORS_NN
REED_NN
ELSEVIER_NN
NV_NN
Summary_NN
of_PIN
the_DT
principal_JJ
differences_NN
between_PIN
Dutch_JJ
and_CC
US_FPP1
GAAP_NN
Reed_NN
Elsevier_NN
NV_NN
accounts_VPRT
for_PIN
its_PIT
50_CD
%_NN
economic_JJ
interest_NN
in_PIN
the_DT
Reed_NN
Elsevier_NN
combined_JJ
businesses_NOMZ
,_,
before_IN
the_DT
effect_NN
of_PIN
tax_NN
credit_NN
equalisation_NOMZ
,_,
by_PIN
the_DT
equity_NOMZ
method_NN
in_PIN
conformity_NOMZ
with_PIN
Dutch_JJ
GAAP_NN
which_WDT [WHSUB]
is_VPRT [BEMA]
similar_PRED
to_PIN
the_DT
equity_NOMZ
method_NN
in_PIN
US_FPP1
GAAP_NN
._.
Using_VBG [PRESP]
the_DT
equity_NOMZ
method_NN
to_TO
present_VB
its_PIT
net_JJ
income_NN
and_PHC
shareholders_NN
funds_NN
under_IN
US_FPP1
GAAP_NN
,_,
Reed_NN
Elsevier_NN
NV_NN
reflects_VPRT [PRIV]
its_PIT
50_CD
%_NN
share_NN
of_PIN
the_DT
effects_NN
of_PIN
differences_NN
between_PIN
Dutch_JJ
and_CC
US_FPP1
GAAP_NN
relating_VBG [WZPRES]
to_PIN
the_DT
combined_VBN
businesses_NOMZ
as_IN
a_DT
single_JJ
reconciling_GER
item_NN
._.
The_DT
most_EMPH
significant_JJ
differences_NN
relate_VPRT
to_PIN
the_DT
capitalization_NOMZ
and_PHC
amortisation_NOMZ
of_PIN
goodwill_NN
and_PHC
intangibles_NN
,_,
pensions_NN
,_,
deferred_VBN
taxes_NN
and_CC
derivative_JJ
financial_JJ
instruments_NOMZ
._.
A_DT
more_EMPH
complete_JJ
explanation_NOMZ
of_PIN
the_DT
accounting_GER
policies_NN
used_VBN [WZPAST]
by_PIN
the_DT
Reed_NN
Elsevier_NN
combined_JJ
businesses_NOMZ
and_CC
the_DT
differences_NN
between_PIN
Dutch_JJ
and_CC
US_FPP1
GAAP_NN
is_VPRT [PASS]
given_VBN
on_PIN
pages_NN
86_CD
and_CC
87_CD
._.
The_DT
Reed_NN
Elsevier_NN
Annual_JJ
Report_NN
2002_CD
on_PIN
Form_NN
20-F_JJ
provides_VPRT
further_JJ
information_NOMZ
for_PIN
US_FPP1
investors_NN
._.
Effects_NN
on_PIN
net_JJ
income_NN
of_PIN
material_NN
differences_NN
between_PIN
Dutch_JJ
and_CC
US_FPP1
GAAP_NN
For_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2002 2002 2001_CD
m_FW
m_FW [BEMA]
Net_JJ
income_NN
under_IN
Dutch_JJ
GAAP_NN
144_CD
101_CD
Impact_NN
of_PIN
US_FPP1
GAAP_NN
adjustments_NOMZ
to_PIN
combined_JJ
financial_JJ
statements_NOMZ
159_CD
106_CD
Net_JJ
income_NN
loss_NN
under_IN
US_FPP1
GAAP_NN
303_CD
5_CD
Earnings_GER
loss_NN
per_PIN
share_NN
under_IN
US_FPP1
GAAP_NN
0.39_CD
0.01_CD
Effects_NN
on_PIN
shareholders_NN
funds_NN
of_PIN
material_NN
differences_NN
between_PIN
Dutch_JJ
and_CC
US_FPP1
GAAP_NN
As_IN
at_PIN
31_CD
December_NN
2002 2002 2001_CD
m_NN
m_NN
Shareholders_NN
funds_NN
under_IN
Dutch_JJ
GAAP_NN
2,034_CD
2,392_CD
Impact_NN
of_PIN
US_FPP1
GAAP_NN
adjustments_NOMZ
to_PIN
combined_JJ
financial_JJ
statements_NOMZ
368_CD
294_CD
Equity_NOMZ
dividends_NN
not_XX0
declared_VBD [PUBV]
in_PIN
the_DT
period_NN
156_CD
157_CD
Shareholders_NN
funds_NN
under_IN
US_FPP1
GAAP_NN
2,558_CD
2,843_CD
92_CD
92_CD
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
ST_NN
REED_NN
ELSEVIER_NN
ANNUAL_NN
REPORTS_NN
&_CC
FINANCIAL_NN
STA_NN
ATEMENTS_NOMZ
2002_CD
TEMENTS_NOMZ
2002_CD
